The Medical Research Council has launched £17 million worth of projects designed to explore the indicators of disease known as biomarkers. Colin Blakemore, chief executive of the MRC, said: "We've been using cholesterol and blood pressure as indicators, or biomarkers, of heart disease for years. Now we're going to evaluate promising markers that will speed the development of safer, more effective and better-targeted treatments for a range of diseases including cancer, cardiovascular disease, stroke and Parkinson's disease."
Please
or to read this article.Register to continue
Get a month's unlimited access to THE content online. Just register and complete your career summary.
Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:
- Sign up for the editor's highlights
- Receive World University Rankings news first
- Get job alerts, shortlist jobs and save job searches
- Participate in reader discussions and post comments
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Subscribe
Already registered or a current subscriber?
